Precipio Stock Price

-0.14 (-3.7%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Precipio Inc PRPO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.14 -3.7% 3.64 12:50:58
Open Price Low Price High Price Close Price Prev Close
3.72 3.53 3.75 3.78
Bid Price Ask Price Spread News
3.64 3.66 0.02 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,004 553,084 $ 3.61 $ 1,998,431 9,118,394 1.06 - 9.18
Last Trade Time Type Quantity Stock Price Currency
12:50:14 1 $ 3.645 USD

Precipio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 82.65M 22.71M 21.88M $ 6.09M $ - -1.03 -11.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 8.27k 38.60%

more financials information »

Precipio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PRPO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.794.653.533.813,122,471-0.15-3.96%
1 Month3.994.653.21293.863,805,461-0.35-8.77%
3 Months2.309.181.724.7915,529,9971.3458.26%
6 Months2.099.181.724.687,638,4491.5574.16%
1 Year1.,949,9702.47211.11%
3 Years0.42510.800.01652.902,942,9553.22756.47%
5 Years8.7028.160.01652.762,380,900-5.06-58.16%

Precipio Description

Precipio Inc is a cancer diagnostics and reagent technology company providing diagnostic products and services to the oncology market. It has built and continues to develop a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technologies developed within academic institutions, and delivering quality diagnostic information to physicians and their patients worldwide. The company also operates a research and development facility in Omaha, Nebraska which focuses on the development of various technologies, among them its internally developed proprietary products IV-Cell and HemeScreen.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.